<DOC>
	<DOC>NCT00819312</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness in terms of prevention of pregnancy and safety of the oral contraceptive YAZ in healthy Chinese women.</brief_summary>
	<brief_title>YAZ, Oral Contraceptive Registration in China</brief_title>
	<detailed_description />
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Healthy women between 18 and 45 requesting oral contraception. Smokers may not exceed 30 years of age. The use of steroidal oral contraceptives , or any drug that could alter oral contraception metabolism will be prohibited during the study. Pregnancy, lactation (less than 3 menstrual cycles since delivery, abortion or lactation before start of treatment) Menstrual disorders suspicious of ovarian failure (e.g. oligomenorrhea, amenorrhea, hypomenorrhea Any disease or condition that may worsen under hormonal treatment Other contraceptive methods such as sterilization or IUD/IUS Substantial overweight (BMI &gt; 30 kg/m2).</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Contraceptives,</keyword>
	<keyword>Oral Hormonal;</keyword>
	<keyword>Contraceptive Methods;</keyword>
	<keyword>Female</keyword>
</DOC>